source
- FDA Commissioner Highlights New Rare Disease Framework Emphasizing Patient VoiceActing US Food and Drug Administration (FDA) Commissioner Kyle Diamantas highlighted the agency's new rare disease framework during a fireside chat at the NORD Breakthrough Summit. The framework i…
- FDA clears Edwards' tricuspid valve repair device; Bayer's blood thinner asundexian approved in ChinaThe U.S. Food and Drug Administration has granted approval for Edwards Lifesciences' new tricuspid valve repair system, expanding treatment options for patients with tricuspid regurgitation. In Ch…